For a drug targeting approach, we undertook subsequent PharmMapper analysis, and it was revealed that 1-MNA targets essential genes such as STAT1, MAPK14, MMP9, and MMP3, which are involved in the progression of RA. The gene discussed is MMP9; the disease is rheumatoid arthritis.